Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net loss $ (5,394) $ (5,619)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization 486 370
Stock-based compensation 828 531
Unrealized (gain) loss on mark-to-market of common stock warrants 819 (435)
Changes in operating assets and liabilities:    
Due to/from related parties (112) (108)
Prepaid expenses and other current assets 56 (110)
Accounts payable (13) (145)
Accrued expenses 879 37
Accrued compensation 73 (313)
Other 3 (612)
Net cash used by operating activities (2,375) (6,404)
Investing activities    
Purchases of land, buildings, and equipment 0 (545)
Net cash (used) provided by investing activities 0 (545)
Financing activities    
Proceeds from the issuance of common stock and pre-funded warrants 0 11,209
Costs incurred related to the issuance of common stock and pre-funded warrants 0 (704)
Proceeds from interim funding provided by Cibus Global, LLC 1,000 0
Repayments of financing lease obligations (97) (94)
Net cash provided by financing activities 903 10,411
Net (decrease) increase in cash, cash equivalents, and restricted cash (1,472) 3,462
Cash, cash equivalents, and restricted cash - beginning of period 3,526 14,421
Cash, cash equivalents, and restricted cash - end of period $ 2,054 $ 17,883